Literature DB >> 19225535

SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis.

R Chaligné, C Tonetti, R Besancenot, C Marty, J-J Kiladjian, G Socié, D Bordessoule, W Vainchenker, S Giraudier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19225535     DOI： 10.1038/leu.2009.22

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses.

Authors:  Leila N Varghese; Daniela Ungureanu; Nicholas P D Liau; Samuel N Young; Artem Laktyushin; Henrik Hammaren; Isabelle S Lucet; Nicos A Nicola; Olli Silvennoinen; Jeffrey J Babon; James M Murphy
Journal:  Biochem J       Date:  2014-03-01       Impact factor: 3.857

Review 2.  Thrombopoietin and hematopoietic stem cells.

Authors:  Carolyn A de Graaf; Donald Metcalf
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

3.  In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: distinct patterns in the different clinical phenotypes.

Authors:  Alessandra Balduini; Stefania Badalucco; Maria Teresa Pugliano; Denis Baev; Annalisa De Silvestri; Marco Cattaneo; Vittorio Rosti; Giovanni Barosi
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

4.  Transcriptome Analysis of Monozygotic Twin Brothers with Childhood Primary Myelofibrosis.

Authors:  Nan Ding; Zhaojun Zhang; Wenyu Yang; Lan Ren; Yingchi Zhang; Jingliao Zhang; Zhanqi Li; Peihong Zhang; Xiaofan Zhu; Xiaojuan Chen; Xiangdong Fang
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-02-07       Impact factor: 7.691
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.